Depression in epilepsy: A complex relation with unexpected consequences

Current Opinion in Neurology

Volumn 21, Issue 2, 2008, Pages 190-194

  Kanner, Andres M ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Selective serotonin reuptake inhibitors; Serotonin binding; Temporal lobe epilepsy

Indexed keywords

MIRTAZAPINE; PLACEBO; SEROTONIN 1A RECEPTOR;

CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; EPILEPSY; HUMAN; MAJOR DEPRESSION; NONHUMAN; PATHOPHYSIOLOGY; POPULATION BASED CASE CONTROL STUDY; REVIEW; SEIZURE;

ANTICONVULSANTS; BRAIN; COMORBIDITY; DEPRESSIVE DISORDER; DRUG RESISTANCE; EPILEPSY; HUMANS; PREVALENCE; RISK FACTORS; SEROTONIN;

EID: 43149106971     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3282f4e978     Document Type: Review

References (20)

1. Mazarati A, Shin D, Auvin S, et al. Kindling epileptogenesis in immature rats leads to persistent depressive behavior. Epilepsy Behav 2007; 10:377-383. This is one of the few experimental research studies published in the literature that investigates the relation between depressive symptoms and epilepsy using animal models of epilepsy and of mood disorders.
2. Tellez-Zenteno JF, Patten SB, Jetté N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007; 48:2336-2344. This is an important study as it portrays a representative prevalence of psychiatric comorbidities in the general population.
3. Christensen J, Vestergaard M, Mortensen PB, et al. Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007; 6:666-667. This population-based study alerts clinicians to the higher suicidal risk of patients with epilepsy, and particularly to its occurrence in the early months after the diagnosis is made.
4. Forsgren L, Nystrom L. An incident case referent study of epileptic seizures in adults. Epilepsy Res 1999; 6:66-81.
5. Hesdorffer DC, Hauser WA, Annegers JF, et al. Major depression is a risk factor for seizures in older adults. Ann Neurol 2000; 47:246-249.
6. Hesdorffer DC, Hauser WA, Olafsson E, et al. Depression and suicidal attempt as risk factor for incidental unprovoked seizures. Ann Neurol 2006; 59:35-41. This important population-based study illustrates the bidirectional relation between mood disorder and epilepsy.
7. Berg AT, Vickrey BG, Testa FM, et al. Behavior and social competency in idiopathic and cryptogenic childhood epilepsy. Dev Med Child Neurol 2007; 49:487-492.
8. Jones JE, Watson R, Sheth R, et al. Psychiatric comorbidity in children with new onset epilepsy. Dev Med Child Neurol 2007; 49:493-497. This study illustrates the relatively frequent existence of psychiatric pathology before the onset of any seizure in children with idiopathic or cryptogenic epilepsy.
9. McAfee AT, Chilcott KE, Johannes CB, et al. The incidence of first unprovoked seizure in pediatric patients with and without psychiatric diagnoses. Epilepsia 2007; 48:1075-1082.
10. Hitiris N, Mohanraj R, Norrie J, et al. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007; 75:192-196. This study demonstrates that a history of depression preceding or present at the onset of epilepsy is predictive of a pharmacoresistant seizure disorder.
11. Anhoury S, Brown RJ, Krishnamoorthy ES, Trimble MR. Psychiatric outcome after temporal lobectomy: a predictive study. Epilepsia 2000; 41:1608-1615.
12. Kanner AM, Byrne R, Smith MC, et al. Does a lifetime history of depression predict a worse postsurgical seizure outcome following a temporal lobectomy? [abstract]. Ann Neurol 2006; 60 (Suppl 10):19.
13. Kanner AM. Current review in clinical science: depression in epilepsy: a neurobiologic perspective. Epilepsy Curr 2005; 5:21-27.
14. Hasler G, Bonwetsch R, Giovacchini G, et al. 5-HT(1A) receptor binding in temporal lobe epilepsy patients with and without major depression. Biol Psychiatry 2007; 62:1258-1264. This study illustrates one of the common pathogenic mechanisms operant in primary depressive disorders and epilepsy.
15. Theodore WH, Giovacchini G, Bonwetsch R, et al. The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography. Epilepsia 2006; 47:499-503. This study illustrates one of the common pathogenic mechanisms operant in primary depressive disorders and epilepsy.
16. Drevets WC, Frank E, Price JC, et al. PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999; 46:1375-1387.
17. 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy. Neurology 2007; 68:364-368.
18. Jobe PC, Dailey JW, Wernicke JF. A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders. Crit Rev Neurobiol 1999; 13:317-356.
19. Alper K, Schwartz KA, Kolts RL, Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007; 62:345-354. This is a pivotal study that demonstrates the safety of using antidepressant drugs of the families of SSRIs and serotonin-norepinephrine reuptake inhibitors with respect to the risk of seizure occurrence.
20. Gilliam FG, Barry JJ, Meador KJ, et al. Rapid detection of major depression in epilepsy: a multicenter study. Lancet Neurol 2006; 5:399-405. This study provides a very practical and user-friendly screening instrument to identify major depressive episodes in epilepsy patients.